Open Access

REVIEW

What Is the Optimal Dose and Schedule for Dasatinib in Chronic Myeloid Leukemia: Two Case Reports and Review of the Literature

Caroline Jamison^*, Debra Nelson^†, Mete Eren^†, Dron Gauchan^†, Ryan Ramaekers^†, Max Norvell^†, Mehmet Sitki Copur^†

* University of Nebraska Medical Center College of Pharmacy, Omaha, NE, USA
† Saint Francis Cancer Treatment Center, Grand Island, NE, USA